Moreover, low levels of AIM2 promoter total methylation might increase the risk of T2DM and AIM2 promoter total methylation or some loss of CpG methylation increase the risk of vascular complications in T2DM (9). This evidence concerns the gene AIM2 and type 2 diabetes mellitus.